ReviewCancer management and research2014

Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib.

Eberechi S Agwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.